SCHEMBL19794360

SCHEMBL19794360

Fc1ccc(-c2ccccc2-c2cc(-c3ccccc3-c3ccc(-c4ccccc4)nc3)cc(-c3ccccc3-c3ccc(-c4ccccc4)nc3)c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP1 P11387 2/20 0.48
ALDH1A3 P47895 1/20 0.48
NPC1 O15118 2/20 0.47
RXFP1 Q9HBX9 1/20 0.47
CYP1A2 P05177 1/20 0.45
CYP2C9 P11712 1/20 0.45
HPGD P15428 1/20 0.45
CYP2C19 P33261 1/20 0.45
PTK2B Q14289 1/20 0.45
CYP11B1 P15538 1/20 0.44
CYP11B2 P19099 1/20 0.44
ADORA1 P30542 2/20 0.44
LDHA P00338 1/20 0.44
ADORA2A P29274 1/20 0.43
HPGDS O60760 2/20 0.43
MAPT P10636 2/20 0.43
FEN1 P39748 1/20 0.43
HSD17B1 P14061 1/20 0.42
HSD17B2 P37059 1/20 0.42
MEN1 O00255 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19794391 0.95 NPC1 (0.51) TOP1ALDH1A3NPC1RXFP1CYP11B1
SCHEMBL18015574 0.90 LDHA (0.52) CYP11B1CYP11B2LDHAHPGDSFEN1
SCHEMBL19933578 0.90 LDHA (0.52) CYP11B1CYP11B2LDHAHPGDSFEN1
SCHEMBL19933728 0.88 LDHA (0.47) CYP11B1CYP11B2LDHAHPGDSFEN1
SCHEMBL19794370 0.88 LDHA (0.50) NPC1CYP11B1CYP11B2LDHAHPGDS
SCHEMBL21721920 0.88 LDHA (0.50) CYP11B1CYP11B2LDHAHPGDSFEN1
SCHEMBL18015495 0.88 LDHA (0.50) NPC1CYP11B1CYP11B2LDHAHPGDS
SCHEMBL19794431 0.88 LDHA (0.50) NPC1CYP11B1CYP11B2LDHAHPGDS
SCHEMBL21125931 0.86 HSD17B1 (0.56) CYP11B1CYP11B2LDHAHPGDSFEN1
SCHEMBL18015685 0.86 TOP1 (0.47) TOP1ALDH1A3NPC1CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11024815-B2 Metal complexes MERCK PATENT GMBH (DE) 2021-06-01 US disclosed
EP-3254317-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-07-31 EP disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 US disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11024815-B2 Metal complexes EXOC4, EXOC3, TIMCC TOP1 3588/4885ALDH1A3 2713/4885NPC1 4039/4885
US-20180026209-A1 Metal Complexes AP3M1, AP2M1, SOD1 TOP1 3428/4885ALDH1A3 1709/4885NPC1 2761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.